Home > Insider Trading > Filing (0001062993-21-005610)

Filing Details

Accession Number:: 0001062993-21-005610
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-06-11 18:41:54
Reporting Period:: 2021-06-09

Accepted Time:: 2021-06-11 18:41:54
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
764195	Vbi Vaccines Inc	VBIV	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1164426	Joseph Edelman	51 Astor Place, 10Th Floor New York NY 10003	No	No	Yes	No
1224962	Perceptive Advisors Llc	51 Astor Place, 10Th Floor New York NY 10003	No	No	Yes	No
1249675	Ltd Fund Master Sciences Life Perceptive	51 Astor Place, 10Th Floor New York NY 10003	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-06-09	1,602,888	$2.75	1,602,888	No	4	X	Indirect	See Footnote
Common Stock	Acquisiton	2021-06-09	465,936	$2.75	465,936	No	4	X	Indirect	See Footnote
Common Stock	Disposition	2021-06-09	1,102,179	$4.00	500,709	No	4	S	Indirect	See Footnote
Common Stock	Disposition	2021-06-09	320,388	$4.00	145,548	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	X	Indirect	See Footnote
No	4	X	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant (right to buy)	Disposition	2021-06-09	1,602,888	$0.00	1,602,888	$2.75
Common Stock	Warrant (right to buy)	Disposition	2021-06-09	465,936	$0.00	465,936	$2.75

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2016-12-06	2021-12-06	No	4	X	Indirect
0	2016-12-06	2021-12-06	No	4	X	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	55,042,456	Indirect	See Footnote

Footnotes

The securities are held directly by Perceptive Credit Holdings, L.P (the "Credit Fund"). Joseph Edelman is the control person of the general partner of the Credit Fund. Each of Mr. Edelman and the Credit Fund's general partner disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
The securities are held directly by PCOF EQ AIV, L.P. ("AIV"). Mr. Edelman is the control person of the general partner of AIV. Each of Mr. Edelman and AIV's general partner disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager of Master Fund. Mr. Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
The exercise price of the warrants was paid on a cashless basis, resulting in the Issuer withholding an aggregate of 1,422,567 of the warrant shares to pay the exercise price.